Supreme Court continues to temporarily maintain mail access to abortion pill
Justice Samuel Alito extended an administrative stay that maintained access to mifepristone through the mail.
Watch CBS News
Justice Samuel Alito extended an administrative stay that maintained access to mifepristone through the mail.
A maker of the widely used abortion pill mifepristone asked the Supreme Court on Saturday to block an appellate court ruling that cut off mail-order access to the drug just a day earlier.
The U.S. Food and Drug Administration is reviewing evidence about the safety and efficacy of the abortion drug mifepristone. The Trump administration says the move is an effort to protect women's health.
The Supreme Court on Thursday tossed out a challenge targeting the availability of a widely used abortion pill, preserving access to the drug.
The abortion pill legislation could be a template for other states to take aim at the medication commonly used in early-stage pregnancies.
Michigan officials released statements as the Supreme Court hears arguments in a case involving the FDA's actions to make mifepristone more accessible.
New research shows that more than six in 10 of the abortions in the U.S. last year were done through medication, up from 53% in 2020.
In January, the FDA changed regulations to allow retail pharmacies to sell the drug mifepristone.
The decision from the Supreme Court blocks lower court orders that would have restricted the availability of the abortion pill mifepristone nationwide.
Limits on how late into a pregnancy the drug can be taken, who can prescribe it and how it can be dispensed were set to take effect Saturday at 1 a.m.
The court maintained access to mifepristone for the time being but is only letting it be dispensed after a doctor's office visit, not by mail, and up to seven weeks into a pregnancy, not 10.
